These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 22674120

  • 1. Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation.
    Bethunaickan R, Sahu R, Liu Z, Tang YT, Huang W, Edegbe O, Tao H, Ramanujam M, Madaio MP, Davidson A.
    Arthritis Rheum; 2012 Oct; 64(10):3399-408. PubMed ID: 22674120
    [Abstract] [Full Text] [Related]

  • 2. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

  • 3. Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
    Ko K, Wang J, Perper S, Jiang Y, Yanez D, Kaverina N, Ai J, Liarski VM, Chang A, Peng Y, Lan L, Westmoreland S, Olson L, Giger ML, Chun Wang L, Clark MR.
    Arthritis Rheumatol; 2016 Nov; 68(11):2740-2751. PubMed ID: 27159593
    [Abstract] [Full Text] [Related]

  • 4. Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
    Lourenço EV, Wong M, Hahn BH, Palma-Diaz MF, Skaggs BJ.
    Arthritis Rheumatol; 2014 Mar; 66(3):674-85. PubMed ID: 24574228
    [Abstract] [Full Text] [Related]

  • 5. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
    Summers SA, Odobasic D, Khouri MB, Steinmetz OM, Yang Y, Holdsworth SR, Kitching AR.
    Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
    [Abstract] [Full Text] [Related]

  • 6. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP.
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [Abstract] [Full Text] [Related]

  • 7. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W, Zheng H, Wu S, Zhang Y, Wang W, Zhang Z, Zhou C, Wu H, Min J.
    Am J Nephrol; 2017 Mar; 46(5):371-379. PubMed ID: 29069649
    [Abstract] [Full Text] [Related]

  • 8. A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.
    Bethunaickan R, Berthier CC, Ramanujam M, Sahu R, Zhang W, Sun Y, Bottinger EP, Ivashkiv L, Kretzler M, Davidson A.
    J Immunol; 2011 Apr 15; 186(8):4994-5003. PubMed ID: 21411733
    [Abstract] [Full Text] [Related]

  • 9. EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon α-accelerated murine lupus.
    Gallo PM, Chain RW, Xu J, Whiteman LM, Palladino A, Caricchio R, Costa-Reis P, Sullivan KE, Gallucci S.
    Int Immunopharmacol; 2024 Oct 25; 140():112692. PubMed ID: 39079344
    [Abstract] [Full Text] [Related]

  • 10. Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.
    Ren J, Liao X, Vieson MD, Chen M, Scott R, Kazmierczak J, Luo XM, Reilly CM.
    Clin Exp Immunol; 2018 Jan 25; 191(1):19-31. PubMed ID: 28876451
    [Abstract] [Full Text] [Related]

  • 11. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
    Liu Z, Bethunaickan R, Huang W, Lodhi U, Solano I, Madaio MP, Davidson A.
    Arthritis Rheum; 2011 Jan 25; 63(1):219-29. PubMed ID: 20954185
    [Abstract] [Full Text] [Related]

  • 12. Macrophage depletion ameliorates nephritis induced by pathogenic antibodies.
    Chalmers SA, Chitu V, Herlitz LC, Sahu R, Stanley ER, Putterman C.
    J Autoimmun; 2015 Feb 25; 57():42-52. PubMed ID: 25554644
    [Abstract] [Full Text] [Related]

  • 13. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
    Xiang L, Liu A, Xu G.
    Am J Physiol Renal Physiol; 2020 May 01; 318(5):F1258-F1270. PubMed ID: 32249615
    [Abstract] [Full Text] [Related]

  • 14. Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin-angiotensin systems.
    Matsuki-Muramoto Y, Nozawa K, Uomori K, Sekigawa I, Takasaki Y.
    Mod Rheumatol; 2017 Jan 01; 27(1):77-86. PubMed ID: 27166507
    [Abstract] [Full Text] [Related]

  • 15. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.
    Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, Madaio MP, Bottinger EP, Davidson A.
    J Immunol; 2008 Feb 01; 180(3):1938-47. PubMed ID: 18209092
    [Abstract] [Full Text] [Related]

  • 16. Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis.
    Kanapathippillai P, Hedberg A, Fenton CG, Fenton KA.
    Cytokine; 2013 May 01; 62(2):244-52. PubMed ID: 23561928
    [Abstract] [Full Text] [Related]

  • 17. A dexamethasone prodrug reduces the renal macrophage response and provides enhanced resolution of established murine lupus nephritis.
    Yuan F, Tabor DE, Nelson RK, Yuan H, Zhang Y, Nuxoll J, Bynoté KK, Lele SM, Wang D, Gould KA.
    PLoS One; 2013 May 01; 8(11):e81483. PubMed ID: 24312306
    [Abstract] [Full Text] [Related]

  • 18. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P, LaStant J, Keirstead N, Whittard T, Ayala J, Stefanova S, Garrido R, Dimaano N, Hilton H, Giron M, Lau KY, Hang J, Postelnek J, Kim Y, Min S, Patel A, Woods J, Ramanujam M, DeMartino J, Narula S, Xu D.
    Arthritis Rheum; 2013 Sep 01; 65(9):2380-91. PubMed ID: 23754328
    [Abstract] [Full Text] [Related]

  • 19. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T cells.
    Yan JJ, Lee JG, Jang JY, Koo TY, Ahn C, Yang J.
    Kidney Int; 2017 Mar 01; 91(3):603-615. PubMed ID: 27914701
    [Abstract] [Full Text] [Related]

  • 20. Glomerular cytokine expression in murine lupus nephritis.
    Tshilela KA, Ikeuchi H, Matsumoto T, Kuroiwa T, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.
    Clin Exp Nephrol; 2016 Feb 01; 20(1):23-9. PubMed ID: 25985839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.